发明名称 |
Kinases as targets for anti-diabetic therapy |
摘要 |
The present invention is related to compound capable of modulating the activity and/or expression of the protein kinases SCYL1, ADCK1, and GRK5, thereby enhancing the expression and/or release of insulin. The invention is further related to methods of identifying said compounds for the treatment of diseases of the carbohydrate metabolism. The invention is further related to methods of treatment of diseases of the carbohydrate metabolism, particularly diabetes mellitus type 2. |
申请公布号 |
AU2011297893(A1) |
申请公布日期 |
2013.03.14 |
申请号 |
AU20110297893 |
申请日期 |
2011.09.05 |
申请人 |
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. |
发明人 |
FALCENBERG, MATHIAS;ULLRICH, AXEL |
分类号 |
A61K31/00;A61K31/713;A61P3/10;C12N15/113 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|